The rapid evolution of the biopharm...

The rapid evolution of the biopharmaceutical industry has lead more and more companies to focus in succession the clinical development of their physic candidates, thus presenting the challenge of selecting the optimal strategy for conducting their clinical programs. Typically, biopharmaceutical companies have had three options: out-licensing their consequence setting up their own clinical evolution operations, or outsourcing the clinical evolution to contract research organizations (CROs)

A recent strategy

A fresh alternative strategy, which combines the best of the latter sum of two units options, ...

Phone Cards , Bowtrol , Weight Watchers Points , Prelox , Designer Handbags Blog